Kudos to CIRM: Stem Cell Agency Sticks with Full Financial Disclosure
A key panel of directors of the $3 billion California stem cell agency yesterday voted unanimously to retain full public disclosure of the financial interests of its directors and top executives.
The director's Governance Subcommitteebypassed a proposal that would have substantially weakened disclosure at a time when the agency is moving closer to indust…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.